OSX 3.33% 6.2¢ osteopore limited

Ann: Suspension from Quotation, page-9

  1. 7,492 Posts.
    lightbulb Created with Sketch. 6758
    Lots of non-holders commentating and very few holders. The last traded price is not reflective of the issue of a ridiculous 10 for 1 dilution, and its price of course dependent on take up, but 30 cents vs the 2.9 cents rights price is a mighty tempted mark-up for share that should, being ex-entitlement, be theoretically trading at a par to the extra 10 for 1 existing.

    Perhaps not quite the doom and gloom the commentators posting on here - the company management appalling undeniably - given the Vietnamese and Singapore approvals. Personally I will be reinjecting the money I made selling at okay levels cum-entitlement and also on the final days trading 500-900% rally in the rights entitlement.

    To give you a clue if the new shares trade half the closing price (presuming the fools managing get the reporting done), they are worth fivefold their cost - not without considerable risk to all invested capital going to zero of course. What bedlam this end of the market. Strong arguments for stronger listing rules and serious amendments/floors in entitlement discounts in Australian Securities law.
    Last edited by bedger: 02/04/24
 
watchlist Created with Sketch. Add OSX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.